PMID: 42116665

The Gastrointestinal Safety of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials.

Hageen Ahmed W, Gadelmawla Ahmed Farid, Saleh Ahmad Omar, Abdallfatah Abdallfatah, Mohamed Mohamed Reyad, El-Nemr Amira Fahmy, Maihoub Odai, Elsekhary Ahmed, Eladawi Safir, Ayalew Biruk Demisse

Endocrinology, diabetes & metabolism · 2026

Vol. 9, Issue 3, pp. e70222

View on PubMed DOI

This entry links to third-party literature. For research use only.

HumansDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsRandomized Controlled Trials as TopicHypoglycemic AgentsGastrointestinal TractAdultOxadiazolesFluorine Compounds

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.